Vaccines, blood, antisera, toxins and cultures in   Niger

Exports In 2022, Niger exported $105k in Vaccines, blood, antisera, toxins and cultures, making it the 130th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 137th most exported product in Niger. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Niger are: Cote d'Ivoire ($61.9k), Mali ($13.4k), Switzerland ($8.8k), France ($6.58k), and South Africa ($6.31k).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Niger between 2021 and 2022 were Cote d'Ivoire ($61.9k), Mali ($10.1k), and Switzerland ($8.8k).

Imports In 2022, Niger imported $71.9M in Vaccines, blood, antisera, toxins and cultures, becoming the 111th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 8th most imported product in Niger. Niger imports Vaccines, blood, antisera, toxins and cultures primarily from: Belgium ($32.6M), South Korea ($8.36M), India ($7.61M), United States ($7.46M), and France ($3.27M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Niger between 2021 and 2022 were Belgium ($19.8M), North Korea ($3.15M), and India ($3.11M).